Fondamentali 304840
PEOPLEBIO, INC. panoramica sulla ripartizione dei ricavi
Il maggior contributo alle entrate proviene da Corea del Sud, da cui PEOPLEBIO, INC. ha incassato 4.43 B KRW nell'ultimo anno, e 4.42 B KRW nell'anno precedente.
Per fonte
2018
2019
2020
2021
2022
2023
0,00
1,20 B
2,40 B
3,60 B
4,80 B
Other Consumable Materials
Oligomerized Beta-amyloid Test
Diamond C (Oligomerized Amyloid Beta Test Automation Equipment)
Other Manufactured Products
Food Material Development, Chemical Substance Development, Supply and Consulting Merchandise
Food Material Development, Chemical Substance Development, Supply and Consulting Product
Food Material Development, Chemical Substance Development, Supply and Consulting
Valuta: KRW
2018
2019
2020
2021
2022
2023
Other Consumable Materials
—
—
—
1,23 B
413,84 M
Oligomerized Beta-amyloid Test
—
—
—
2,82 B
128,24 M
Diamond C (Oligomerized Amyloid Beta Test Automation Equipment)
—
—
—
385,00 M
35,00 M
Other Manufactured Products
—
—
—
17,50 M
—
Food Material Development, Chemical Substance Development, Supply and Consulting Merchandise
—
29,00 M
448,84 M
—
—
Food Material Development, Chemical Substance Development, Supply and Consulting Product
—
478,85 M
128,24 M
—
—
Food Material Development, Chemical Substance Development, Supply and Consulting
895,04 M
—
—
—
—
Per paese
2018
2019
2020
2021
2022
2023
0,00
1,20 B
2,40 B
3,60 B
4,80 B
South Korea
Asia
Europe
Valuta: KRW
2018
2019
2020
2021
2022
2023
South Korea
895,04 M
507,85 M
537,64 M
4,42 B
4,43 B
Asia
—
—
39,44 M
29,17 M
18,37 M
Europe
—
—
—
—
2,31 M